Baloise stock holds above CHF 209 as analysts turn cautious

Baloise (CH0012410517) stock traded at CHF 209.80 on August 21, 2026, up 0.77 percent on the session and down 3.07 percent since the start of 2026.

Latest market read

The shares also sat below a recent CHF 215.20 close from August 14, 2026, which gives the move a clear reference point for investors watching the Swiss insurer's summer trading range. The stock is still more than 6,000 basis points below a 52-week level that matters for short-term positioning.

Half-year numbers

Baloise reported revenue of CHF 4.41 billion for the first half of 2026 and net profit of CHF 275 million in that same period. The comparison is straightforward: revenue was up 4.0 percent year over year, while profit also improved from the prior-year period.

The half-year update also pointed to a stronger operating backdrop in the business mix, with the insurer's results supported by its core insurance lines and investment performance. For holders, the key number is the gap between the August share price and the profit base that is now visible in the first-half figures.

Portfolio angle

That makes the market's focus narrower than a generic insurer rerating story. The stock is trading with a modest year-to-date setback, but the latest reported profit figure gives the valuation debate a current earnings anchor.

More on Baloise stock

Baloise's product set spans life insurance, non-life insurance, asset management, and banking services across its home market and neighboring countries. That mix matters because it links premium growth, claims trends, and investment income into one earnings profile.

Price check

As of August 21, 2026, Baloise stock traded at CHF 209.80 on the SIX Swiss Exchange.

Company snapshot

Company: Baloise Holding AG

ISIN: CH0012410517

Ticker: BALN

Exchange: SIX Swiss Exchange

Price (as of August 21, 2026, 11:20 a.m. EDT): CHF 209.80

Sector / Industry: Financials / Insurance

Index membership: SMI